Boxer Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-825,000
Closed -$32.5M 83
2023
Q2
$32.5M Hold
825,000
1.51% 21
2023
Q1
$20.1M Hold
825,000
0.99% 33
2022
Q4
$17.7M Buy
+825,000
New +$17.6M 0.93% 36

Boxer Capital's ISEE Position: Q3 2023 in Review

Boxer Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 825,000 shares — an estimated $32.5M sold.

Boxer Capital first reported a position in ISEE in Q4 2022 and held it in 3 quarters. The position peaked at $32.5M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Boxer Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Boxer Capital sold 825,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $32.5M.
  • Boxer Capital first reported a position in IVERIC bio, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Boxer Capital's IVERIC bio, Inc. Common Stock position peaked at $32.5M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Boxer Capital's 13F filing for Q3 2023, filed 14 Nov 2023.